SCHEMBL18311367

SCHEMBL18311367

CC(C)c1ccc(C(=O)NC(C)c2cncc(OCC(F)(F)F)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 1/20 0.51
CACNA1H O95180 1/20 0.51
CNR2 P34972 1/20 0.51
KCNH2 Q12809 1/20 0.51
CACNA1I Q9P0X4 1/20 0.51
SIRT2 Q8IXJ6 1/20 0.44
SIRT1 Q96EB6 1/20 0.44
SIRT3 Q9NTG7 1/20 0.44
PTGER4 P35408 3/20 0.43
ROCK1 Q13464 7/20 0.43
ROCK2 O75116 5/20 0.43
PRKACA P17612 3/20 0.43
GSK3A P49840 3/20 0.43
GSK3B P49841 3/20 0.43
PRKX P51817 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
PRKG1 Q13976 3/20 0.43
RPS6KB1 P23443 2/20 0.43
CDK2 P24941 2/20 0.43
AKT2 P31751 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18311366 1.00 CACNA1G (0.51) CACNA1GCACNA1HCNR2KCNH2CACNA1I
SCHEMBL17240479 0.90 ROCK2 (0.45) CACNA1GCACNA1HCNR2KCNH2CACNA1I
SCHEMBL2137322 0.81 CACNA1I (0.75) CACNA1GCACNA1HCNR2KCNH2CACNA1I
SCHEMBL2136279 0.81 CACNA1I (0.75) CACNA1GCACNA1HCNR2KCNH2CACNA1I
SCHEMBL2136274 0.81 CACNA1I (0.75) CACNA1GCACNA1HCNR2KCNH2CACNA1I
SCHEMBL27931750 0.78 SMN1; SMN2 (0.53) CACNA1GCACNA1HCNR2KCNH2CACNA1I
SCHEMBL10174185 0.78 CYP17A1 (0.43) CACNA1GCACNA1HCNR2KCNH2CACNA1I
SCHEMBL27931767 0.77 ROCK1 (0.64) ROCK1ROCK2PRKACAGSK3AGSK3B
SCHEMBL17240495 0.76 PHGDH (0.55)
SCHEMBL17240494 0.76 PHGDH (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522140-B2 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers RAQUALIA PHARMA INC. (JP) 2016-12-20 US disclosed